SE468882B - Anvaendning av erytro-dops foer framstaellning av ett laekemedel foer behandling av psykomotorisk roerelse - Google Patents

Anvaendning av erytro-dops foer framstaellning av ett laekemedel foer behandling av psykomotorisk roerelse

Info

Publication number
SE468882B
SE468882B SE8404715A SE8404715A SE468882B SE 468882 B SE468882 B SE 468882B SE 8404715 A SE8404715 A SE 8404715A SE 8404715 A SE8404715 A SE 8404715A SE 468882 B SE468882 B SE 468882B
Authority
SE
Sweden
Prior art keywords
dops
erythro
movement
mice
administered
Prior art date
Application number
SE8404715A
Other languages
English (en)
Swedish (sv)
Other versions
SE8404715D0 (sv
SE8404715L (sv
Inventor
T Mori
T Nakajima
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58175581A external-priority patent/JPS6067420A/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE8404715D0 publication Critical patent/SE8404715D0/xx
Publication of SE8404715L publication Critical patent/SE8404715L/
Publication of SE468882B publication Critical patent/SE468882B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8404715A 1983-09-22 1984-09-20 Anvaendning av erytro-dops foer framstaellning av ett laekemedel foer behandling av psykomotorisk roerelse SE468882B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58175581A JPS6067420A (ja) 1983-09-22 1983-09-22 精神運動興奮抑制剤
CA000452844A CA1225598A (en) 1983-09-22 1984-04-26 Pharmaceutical composition and method for treatment of psychomotor excitement

Publications (3)

Publication Number Publication Date
SE8404715D0 SE8404715D0 (sv) 1984-09-20
SE8404715L SE8404715L (sv) 1985-03-23
SE468882B true SE468882B (sv) 1993-04-05

Family

ID=25670371

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404715A SE468882B (sv) 1983-09-22 1984-09-20 Anvaendning av erytro-dops foer framstaellning av ett laekemedel foer behandling av psykomotorisk roerelse

Country Status (10)

Country Link
BE (1) BE900654A (de)
CH (1) CH664493A5 (de)
DE (1) DE3433675A1 (de)
FR (1) FR2552327B1 (de)
GB (1) GB2146899B (de)
IT (1) IT1175863B (de)
MX (1) MX167915B (de)
NL (1) NL8402850A (de)
NZ (1) NZ209514A (de)
SE (1) SE468882B (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920728A (en) * 1973-08-22 1975-11-18 Hoffmann La Roche Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
CH580059A5 (de) * 1973-08-22 1976-09-30 Hoffmann La Roche
NL7700945A (nl) * 1976-02-13 1977-08-16 Merck & Co Inc Werkwijze voor het bereiden van bloeddruk- verhogende preparaten.
JPS52125630A (en) * 1976-04-14 1977-10-21 Kyowa Hakko Kogyo Co Ltd Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS56104815A (en) * 1980-01-23 1981-08-20 Sumitomo Chem Co Ltd Remedy for peripheral orthostatic hypotension
JPS5852219A (ja) * 1981-09-22 1983-03-28 Sumitomo Chem Co Ltd パ−キンソン病治療剤

Also Published As

Publication number Publication date
GB2146899A (en) 1985-05-01
CH664493A5 (de) 1988-03-15
MX167915B (es) 1993-04-22
NZ209514A (en) 1988-03-30
DE3433675A1 (de) 1985-04-11
IT1175863B (it) 1987-07-15
FR2552327A1 (fr) 1985-03-29
BE900654A (fr) 1985-03-21
FR2552327B1 (fr) 1988-01-15
SE8404715D0 (sv) 1984-09-20
NL8402850A (nl) 1985-04-16
SE8404715L (sv) 1985-03-23
GB8423725D0 (en) 1984-10-24
IT8422685A1 (it) 1986-03-17
GB2146899B (en) 1987-11-25

Similar Documents

Publication Publication Date Title
Friedlander et al. Alzheimer's disease: psychopathology, medical management and dental implications
US20060276412A1 (en) Methods and compositions for managing psychotic disorders
Chase et al. Parkinson's disease: Modification by 5‐hydroxytryptophan
Rivera-Calimlim et al. The clinical picture and plasma levodopa metabolite profile of parkinsonian nonresponders: Treatment with levodopa and decarboxylase inhibitor
US9504665B2 (en) High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders
AU2004296790A1 (en) Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality
US4529603A (en) Pharmaceutical composition and method for treatment of psychomotor excitement
Rose et al. Studies on isoxsuprine hydrochloride for the treatment of navicular disease
JPH0227327B2 (de)
Fann et al. Effect of iprindole on amine uptake in man
Steingard et al. Neuroleptic malignant syndrome: review of experience with children and adolescents
EP1247533A2 (de) Kombinationsbehandlung von multipler Sklerose, anderen demyelinisierenden Erkrankungen und peripherer Neuropathie, insbesondere schmerzhaften Neuropathien und diabetischer Neuropathie
US6713493B2 (en) Use of nicergoline in the treatment of spasticity
Robinson Obsessive-compulsive disorder in children and adolescents
US20190350918A1 (en) PPARy AGONIST FOR TREATMENT OF HUNTINGTON'S DISEASE
Hamburg et al. Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy
Sandor et al. Remoxipride in the treatment of levodopa-induced psychosis
Gordon et al. Subacute necrotising encephalomyelopathy in three siblings
NZ209514A (en) Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor
Wittenborn Deductive approaches to the catecholamine hypothesis of affective disorders
Fabiana et al. Side Effects of phenytoin in the oral cavity: A review
EP4257147A1 (de) Augentropfen zur hemmung der myopieprogression bei kindern und screening-verfahren für einen hemmer der myopieprogression bei kindern
Roberts et al. Energy consumption in spasticity
Jawaid et al. Pharmacological treatment of bipolar affective disorder in old age
Obayi et al. Neuroleptic malignant syndrome: A review of the clinical/diagnostic features and report of a case without fever

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8404715-8

Effective date: 19930512